Melanoma treatment: where are we now and what's on the horizon?

By Pavlick Anna C  

Clinical Practice, Vol. 10, Iss. 3, 2013-05 ,pp. : 237-240

Future Medicine

Access to resources Recommend Favorite

What is the best quality of diabetes care? The Global Diabetes Survey needs your participation

By Schwarz Peter E. H.  

Medical Writing, Vol. 21, Iss. 4, 2012-12 ,pp. : 288-290

Maney Publishing

Access to resources Recommend Favorite

What influence have national service frameworks had on the priorities of primary care groups and trusts?

By Banks-Smith J.  

The Journal of Clinical Governance, Vol. 10, Iss. 1, 2002-03 ,pp. : 7-11

Radcliffe Press

Access to resources Recommend Favorite

Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimer's Disease

By  

Recent Patents on CNS Drug Discovery, Vol. 5, Iss. 2, 2010-01 ,pp. : 109-117

Bentham Science Publishers

Access to resources Recommend Favorite

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

By Klonoff David C.   Buse John B.   Nielsen Loretta L.   Guan Xuesong   Bowlus Christopher L.   Holcombe John H.   Wintle Matthew E.   Maggs David G.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 275-286

Informa Healthcare

Access to resources Recommend Favorite